Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Apple
AAPL
|
+$880M |
| 3 |
Merck
MRK
|
+$323M |
| 4 |
Medtronic
MDT
|
+$317M |
| 5 |
Amazon
AMZN
|
+$314M |
Top Sells
| 1 |
Walt Disney
DIS
|
+$741M |
| 2 |
NXP Semiconductors
NXPI
|
+$597M |
| 3 |
Intuit
INTU
|
+$468M |
| 4 |
Meta Platforms (Facebook)
META
|
+$447M |
| 5 |
Advanced Micro Devices
AMD
|
+$385M |
Sector Composition
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.19% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
2001
DELISTED
Immunogen Inc
IMGN
| $5.55M | ﹤0.01% |
860,912
+26,609
| +3% | +$172K |
|
2002
Pitney Bowes
PBI
$1.96B
| $5.55M | ﹤0.01% |
900,525
+17,936
| +2% | +$111K |
|
2003
Alamo Group
ALG
$2.49B
| $5.52M | ﹤0.01% |
40,035
-4,949
| -11% | -$683K |
|
2004
Zentalis Pharmaceuticals
ZNTL
$107M
| $5.51M | ﹤0.01% |
105,992
+65,359
| +161% | +$3.39M |
|
2005
The Greenbrier Companies
GBX
$1.42B
| $5.5M | ﹤0.01% |
151,170
+3,361
| +2% | +$122K |
|
2006
Reynolds Consumer Products
REYN
$4.84B
| $5.5M | ﹤0.01% |
182,924
-310,781
| -63% | -$9.34M |
|
|
AERI
2007
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.5M | ﹤0.01% |
406,733
-191,751
| -32% | -$2.59M |
|
2008
iQIYI
IQ
$2.51B
| $5.47M | ﹤0.01% |
313,168
+35,268
| +13% | +$616K |
|
2009
Acadia Realty Trust
AKR
$2.64B
| $5.47M | ﹤0.01% |
385,480
-18,696
| -5% | -$265K |
|
2010
iShares MSCI EAFE ETF
EFA
$67.1B
| $5.44M | ﹤0.01% |
74,603
-2,565,935
| -97% | -$187M |
|
2011
QCR Holdings
QCRH
$1.3B
| $5.43M | ﹤0.01% |
137,254
-15,025
| -10% | -$595K |
|
2012
Castle Biosciences
CSTL
$621M
| $5.43M | ﹤0.01% |
80,793
-3,509
| -4% | -$236K |
|
2013
Universal Corp
UVV
$1.38B
| $5.42M | ﹤0.01% |
111,508
-1,728
| -2% | -$84K |
|
2014
Marcus & Millichap
MMI
$1.26B
| $5.4M | ﹤0.01% |
145,089
+26,639
| +22% | +$992K |
|
2015
Codexis
CDXS
$219M
| $5.4M | ﹤0.01% |
247,345
+18,394
| +8% | +$402K |
|
2016
QuinStreet
QNST
$930M
| $5.4M | ﹤0.01% |
251,769
+1,001
| +0.4% | +$21.5K |
|
2017
Safety Insurance
SAFT
$1.1B
| $5.38M | ﹤0.01% |
69,037
-541
| -0.8% | -$42.1K |
|
2018
Collegium Pharmaceutical
COLL
$1.18B
| $5.37M | ﹤0.01% |
268,266
-12,171
| -4% | -$244K |
|
2019
PTC Therapeutics
PTCT
$4.85B
| $5.36M | ﹤0.01% |
258,115
-2,914
| -1% | -$60.5K |
|
2020
nLIGHT
LASR
$1.43B
| $5.36M | ﹤0.01% |
164,012
+10,465
| +7% | +$342K |
|
2021
Relay Therapeutics
RLAY
$688M
| $5.35M | ﹤0.01% |
128,691
+2,652
| +2% | +$110K |
|
2022
Oxford Industries
OXM
$704M
| $5.34M | ﹤0.01% |
81,574
-555
| -0.7% | -$36.4K |
|
|
JOYY
2023
JOYY Inc. American Depositary Shares
JOYY
$3.21B
| $5.32M | ﹤0.01% |
66,520
-3,784
| -5% | -$303K |
|
2024
Arcus Biosciences
RCUS
$1.23B
| $5.32M | ﹤0.01% |
204,789
-11,563
| -5% | -$300K |
|
|
AAN
2025
DELISTED
The Aaron's Company, Inc.
AAN
| $5.31M | ﹤0.01% |
+280,266
| New | +$5.31M |
|